Valuation : Kenvue Inc.

Market Cap 36.4B 31.32B 29.39B 26.89B 50.19B 3,441B 50.58B 348B 135B 1,758B 137B 134B 5,663B P/E 2026 *
19.9x
P/E 2027 * 17.3x
Enterprise Value 43.5B 37.42B 35.12B 32.13B 59.97B 4,112B 60.45B 415B 162B 2,101B 163B 160B 6,767B EV / Sales 2026 *
2.79x
EV / Sales 2027 * 2.69x
Free-Float
98.88%
Yield 2026 *
4.45%
Yield 2027 * 4.55%
1 day-0.94%
1 week-1.30%
Current month+0.37%
1 month-0.32%
3 months+12.60%
6 months+4.41%
Current year+9.86%
1 week 18.71
Extreme 18.71
19.18
1 month 18.65
Extreme 18.65
19.7
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.69
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%-1.30%-7.33%-17.47% 36.74B
-0.49%+2.64%-7.11%-4.91% 343B
-1.04%-0.82%-11.02%+4.42% 139B
-0.01%-0.96%+7.49%+22.96% 71.83B
-0.66%-2.92%-26.71%-21.67% 49.12B
-0.29%-5.04%+9.71%-37.63% 36.6B
-1.18%-3.01%+2.20%+22.77% 20.43B
-0.65%-2.85%+7.73%+7.82% 19.37B
-0.78%-5.54%-21.68%-37.44% 19.47B
-2.76%-4.64%-31.45%-12.47% 9.8B
Average -0.88%-1.76%-7.82%-7.36% 74.54B
Weighted average by Cap. -0.63%+0.36%-6.97%-3.67%

Financials

2026 *2027 *
Net sales 15.6B 13.42B 12.59B 11.52B 21.5B 1,474B 21.67B 149B 58.01B 753B 58.56B 57.29B 2,426B 15.97B 13.74B 12.89B 11.79B 22.01B 1,509B 22.19B 153B 59.39B 771B 59.96B 58.65B 2,484B
Net income 1.83B 1.57B 1.48B 1.35B 2.52B 173B 2.54B 17.48B 6.81B 88.4B 6.87B 6.72B 285B 2.11B 1.82B 1.71B 1.56B 2.91B 200B 2.94B 20.18B 7.86B 102B 7.93B 7.76B 329B
Net Debt 7.1B 6.11B 5.73B 5.24B 9.79B 671B 9.86B 67.79B 26.4B 343B 26.65B 26.07B 1,104B 6.52B 5.61B 5.26B 4.82B 8.99B 616B 9.06B 62.27B 24.25B 315B 24.48B 23.95B 1,014B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-09-03 US$18.95 -0.94% 18,570,089
26-09-02 US$19.13 +2.03% 19,692,893
26-09-01 US$18.75 -0.69% 21,754,679
26-08-31 US$18.88 -1.51% 27,072,043
26-08-28 US$19.17 -0.16% 11,888,632
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
18.95USD
Average target price
19.50USD
Spread / Average Target
+2.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock